✦ LIBER ✦

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia

✍ Scribed by Halla S. Nimeiri; Amit M. Oza; Robert J. Morgan; Dezheng Huo; Laurie Elit; James A. Knost; James L. Wade III; Edem Agamah; Everett E. Vokes; Gini F. Fleming

Book ID: 113962387
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 230 KB
Volume: 117
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.01.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study single agent of afliber

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

✍ H.J. Mackay; R.J. Buckanovich; H. Hirte; R. Correa; P. Hoskins; J. Biagi; L.P. M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 309 KB

A phase I/II trial of sorafenib and infl

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

✍ Larkin, J M G; Ferguson, T R; Pickering, L M; Edmonds, K; James, M G; Thomas, K; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 226 KB

A phase II trial of sunitinib in women w

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

✍ Castonguay, Vincent; Lheureux, Stephanie; Welch, Stephen; Mackay, Helen J.; Hirt 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 387 KB

A phase II study of paclitaxel in advanc

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

✍ Scagliotti, Giorgio V.; Smit, Egbert; Bosquee, Lionel; Brien, Mary O’; Ardizzoni 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

658Radiotherapy and hyperthermia for adv

658Radiotherapy and hyperthermia for advanced carcinomas of the uterine cervix — Results of a phase II trial

✍ S. Dinges; C. Harder; A. Buchali; I.-G. Kaufmann; J. Gellermann; P. Wust; V. Bud 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Phase II Study of the Oral MEK Inhibitor

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

✍ Jain, N.; Curran, E.; Iyengar, N. M.; Diaz-Flores, E.; Kunnavakkam, R.; Popplewe 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 462 KB